Surrozen (SRZN)

Technical Analysis Historical Data Financials News & Analysis

SRZN NEWS

HC Wainwright Reiterates “Buy” Rating for Surrozen (NASDAQ:SRZN) By MarketBeat - 3 weeks ago

Surrozen (NASDAQ:SRZN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $32.00 target p… [+3255 chars]...

Read more
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway By Site Author - 3 weeks ago

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -in… [+9220 chars]...

Read more
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update By Site Author - 4 weeks ago

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modula… [+18545 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		210.81 1.79
0.86%
CVX 		140.18 3.28
2.4%
CAT 		353.35 4.39
1.26%
INTC 		20.04 0.05
0.23%
MSFT 		470.38 2.7
0.58%
DIS 		113.89 1.36
1.21%
DOW 		28.55 0.37
1.31%
CSCO 		66.06 1.44
2.23%
GS 		614 8.12
1.34%